Vision Lab Choice Act of 2025
- Sponsor
- Sen. Cramer, Kevin [R-ND]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- May 12, 2025
Bottom line
The bill aims to increase optometrist autonomy and choice in vision care by limiting contract terms and prohibiting restrictions on lab and supplier selection, though its federal impact is limited by a state law preemption clause.
What it actually does
This bill amends the Public Health Service Act to regulate certain aspects of vision plans. Specifically, it limits the initial and renewal terms of agreements between optometrists and vision plans to two years, and prohibits vision plans from restricting optometrists' choice of laboratories or suppliers for services and materials. It also includes a significant clause stating that existing state laws conflicting with these federal amendments will take precedence.
Proponents argue
Supporters argue that this bill will empower optometrists by giving them more control over their practice and the materials they use, fostering competition among labs and suppliers, and potentially leading to better quality care and more choices for patients. They contend that current practices by vision plans can limit optometrists' professional judgment and restrict patient access to preferred services or products.
Opponents contend
Opponents might argue that the bill interferes with private contractual agreements and could disrupt existing managed care networks, potentially increasing administrative costs for vision plans. They might also contend that plans' current restrictions are designed to ensure quality control, cost efficiency, and network consistency, and that removing these could lead to higher costs for consumers or reduced plan oversight.
The bill is very short and can be read and understood quickly by an informed reader.
Section 2(a), new Section 2719B(a)(1) of the PHS Act
Limits on Vision Plan Agreement Durations
This provision mandates that initial agreements between doctors of optometry and group health plans or health insurance coverage offering limited scope vision benefits cannot exceed two years. Any extensions to these agreements also cannot be longer than two years and require the optometrist's prior acceptance. While unlimited extensions are permitted, each must adhere to the two-year term limit.
Supporters argue
Supporters argue that shorter contract terms and required consent for extensions provide optometrists with greater autonomy and leverage in negotiations, preventing them from being locked into unfavorable long-term agreements. This can foster a more equitable relationship between providers and plans.
Critics contend
Critics may contend that limiting contract durations could increase administrative burdens and costs for vision plans, as they would need to renegotiate agreements more frequently. This could also lead to instability in provider networks and potentially higher costs passed on to consumers.
Tradeoffs
This provision balances provider autonomy and flexibility against the administrative efficiency and network stability sought by vision plan issuers. Shorter terms empower providers but may introduce more frequent renegotiations for plans.
Section 2(a), new Section 2719B(a)(2) of the PHS Act
Prohibition on Restricting Lab and Supplier Choice
This provision prohibits group health plans or health insurance issuers offering vision coverage from directly or indirectly restricting a doctor of optometry's choice of laboratories, or their choice of source or supplier for services or materials provided to an enrolled individual. This means optometrists would have full discretion in selecting where to obtain lenses, frames, and other vision care materials.
This section amends Section 2722(c)(1) of the Public Health Service Act by inserting "(other than the requirements under section 2719B)" after "section 2791(c)(2)". This means the new requirements regarding vision plans are explicitly excluded from certain existing rules related to state flexibility or preemption under the PHS Act.
Section 2(b) - Conforming Amendment
Why it matters:This is standard legislative practice for integrating new provisions into existing legal frameworks, ensuring consistency and clarifying applicability. It's not necessarily evasive.
Case for: Supporters would argue this amendment is necessary to properly integrate the new vision plan regulations into the broader Public Health Service Act, ensuring clarity on which existing rules apply or do not apply to the new section.
Case against: No specific opposition is typically raised against conforming amendments, as they are technical in nature, though the underlying policy they clarify might be contentious.
Estimated impact: The impact is to ensure the new federal vision plan rules operate as intended without being undermined or altered by other preemption or state flexibility clauses in the PHS Act. Its direct financial impact is negligible, but its legal effect is significant for the bill's enforceability.
This section states that, notwithstanding any amendments made by this Act, State law that directly affects any standard or requirement relating to health insurance issuers and vision benefit plans shall have exclusive application if it conflicts with the federal amendments. Furthermore, States retain exclusive jurisdiction over health insurance issuers and limited scope vision benefit plans directly governed by such State law.
Section 2(c) - Exclusive Applicability of State Law
Why it matters:This could be seen as a compromise to gain broader support by addressing concerns about federal overreach into state-regulated insurance markets. While technically a 'limitation' on the bill's federal scope, its placement at the end might make it less prominent.
Case for: Supporters of this clause would argue it respects states' rights and existing regulatory frameworks, preventing federal mandates from overriding potentially more tailored or robust state-level consumer protections or market regulations already in place for vision plans. It ensures states can maintain their authority.
Case against: Critics might argue that this clause significantly weakens the federal bill's intended impact, creating a patchwork of regulations where the federal provisions only apply in states without conflicting laws. This could lead to uneven consumer and provider protections across the country and undermine the goal of national standards.
Estimated impact: This provision significantly limits the federal bill's practical effect, potentially rendering it inoperative in states with existing conflicting laws. Its impact is to preserve state regulatory authority, potentially reducing the uniformity of vision plan regulations nationwide.